Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

#MK2140

Home » #MK2140
Dr. Alexander Fosså:Phase II waveLINE-004 Study of ROR1-ADC Treatment for R/R DLBCL

Dr. Alexander Fosså:Phase II waveLINE-004 Study of ROR1-ADC Treatment for R/R DLBCL

Posted by By Kenzy Nour 2024.01.11
On the 17th International Conference on Malignant Lymphoma (ICML), Dr. Alexander Fosså from Oslo University Hospital presented the results of the Zilovertamab vedotin (MK-2140) treatment for relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL), a Phase II open-label, waveLINE-004 study. Oncology Frontier interviewed Dr. Fosså at the conference.
Read More
Recent Posts
  • ESMO Voices from China | Professor Hongxia Wang: B7-H3-Targeted ADC SYS6043 Shows Encouraging Antitumor Activity and Manageable Safety in Advanced Breast Cancer
  • ESMO Voices from China | Professor Jian Zhang: BFv Offers New Hope for Later-Line TNBC Treatment After Resistance to TOP1 Inhibitor-Based ADCs
  • 2026 Breast Cancer Quality Control Conference | Professor Qiao Li: Fertility Preservation and Rational Drug Use
  • 2026 Breast Cancer Quality Control Conference | Professor Fei Ma: Reviewing Progress and Shaping the Future of Breast Cancer Quality Control
  • ESMO LBA Insights | Professor Jong Chul Park Discusses the HexAgon-HN Study
Recent Comments
    Archives
    • November 2026
    • October 2026
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top